NCT05067803

Brief Summary

The product is comprised of software that aids in automated guided ultrasound image acquisition for novice users (medical professional without experience in performing echocardiography, e.g. nurses, physicians assistants, medical doctors, medical student etc.). The software provides real-time feedback during image acquisition to optimize image capture and determine whether image quality is sufficient for medical evaluation. The software is designed to be used with any echocardiographic ultrasound system. The Philips Lumify hand-held ultrasound device will be used for this study.

  • Images can be acquired manually by a novice user.
  • Each novice user will have a training course of 8 hours, before the study commences.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 5, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

December 24, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 23, 2022

Completed
Last Updated

April 11, 2022

Status Verified

February 1, 2022

Enrollment Period

1 month

First QC Date

September 23, 2021

Last Update Submit

April 3, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • To assess the quality of clips obtained by novice users when using the USEG software.

    The expert cardiologists will evaluate whether the echo examination has sufficient to evaluate each of the primary endpoints: 1. Sufficient quality to assess Left Ventricular (LV) size: (YES/NO) 2. Sufficient quality to assess LV function: (Yes/No) 3. Sufficient quality to assess Right Ventricular size: (Yes/No) 4. Sufficient quality to assess presence of non-trivial pericardial effusion: (Yes/No)

    1 year.

Secondary Outcomes (2)

  • Sufficient quality assessment for six (6) anatomic elements.

    1 year.

  • Diagnostic quality assessment.

    1 year.

Other Outcomes (1)

  • Safety outcome.

    1 year.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Up to 100 male and female adults confirmed as eligible according to eligibility criteria.

You may qualify if:

  • Age 18 and older
  • Subjects willing and able to give written informed consent.

You may not qualify if:

  • Emergency (non-elective) admission within 24 h prior to participating in the study
  • Female subjects who are pregnant (WOCBP\* will perform a urine pregnancy test)
  • Unable to lie as required in all the classic positions for standard TTE exam: supine on back / left decubitus.
  • Subjects who currently participate a clinical trial, involving interventional cardiac devices
  • Subjects who have prior Echo exam with description of Low/Poor quality exam in the echo report
  • Subjects with BMI above 40
  • Subjects experiencing a known or suspected acute cardiac event
  • Subjects with severe chest wall deformity as per previous medical records and physical examination
  • Subjects who have undergone pneumonectomy
  • Subjects whose anatomy does not lend itself to yield diagnosable echocardiography clips (i.e. situs inversus with dextrocardia, single ventricle anatomy due to congenital heart defect, etc.)
  • A woman is of childbearing potential if she is postmenarchal, has not reached a postmenopausal state (≥12 continuous months of amenorrhea with no identified cause other than menopause), and is not permanently infertile due to surgery (i.e., removal of ovaries, fallopian tubes, and/or uterus) or another cause as determined by the investigator (e.g., Müllerian agenesis.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheba MC

Ramat Gan, Israel

Location

MeSH Terms

Conditions

Heart Diseases

Condition Hierarchy (Ancestors)

Cardiovascular Diseases

Study Officials

  • Robert Klempfner, MD

    Sheba MC

    PRINCIPAL INVESTIGATOR
  • Danny Spiegelstein, MD

    UltraSight

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2021

First Posted

October 5, 2021

Study Start

December 24, 2021

Primary Completion

January 23, 2022

Study Completion

January 23, 2022

Last Updated

April 11, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations